Halozyme Therapeutics Inc 2022 Sustainability Report
Company: Halozyme Therapeutics Inc
Sector: Manufacturing
Country: United States
Year: 2022
Type: Sustainability Report
Pages: 28
The report describes Halozyme's 2022 ESG priorities across employee inclusion, product quality and safety, governance and ethics, community engagement, and environmental stewardship. It reports a 43.8% female employee base and a 35% female senior leadership population as of December 1, 2022. Operational highlights include a global EHS program, expanded C.A.R.E. Squad community chapters, climate-risk integration into enterprise risk management, and a laboratory Waste-to-Energy program.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.